Genomic surveillance of H1N1, H3N2 and influenza B Victoria lineage viruses in Qingyang (2020-2023): phylogenetic and molecular characteristics analysis of HA/NA genes

青阳市H1N1、H3N2和B型流感Victoria谱系病毒基因组监测(2020-2023年):HA/NA基因的系统发育和分子特征分析

阅读:1

Abstract

BACKGROUND: HA and NA are important surface proteins of influenza viruses. The purpose of this study was to explore the molecular evolution and amino acid mutations of HA and NA of H1N1, H3N2 and Influenza B Victoria lineage (B/Victoria) viruses in Qingyang from 2020 to 2023. METHODS: Through the China Influenza Surveillance Information System, the positive data of influenza etiology surveillance in Qingyang from 2020 to 2023 were screened. A total of 19 samples of H1N1, 47 samples of H3N2 and 51 samples of B/Victoria were screened. Subsequently, virus nucleic acid extraction, whole genome sequencing, amino acid and nucleotide homology analysis, phylogenetic analysis, and amino acid site mutation analysis were performed. RESULTS: Miniseq sequencing was performed on 117 influenza strains. Homology analysis showed that H1N1 and H3N2 strains had relatively low homology with vaccine representative strains. Amino acid mutation analysis of HA and NA showed that the H1N1 strains had receptor binding site and antigen site mutations, but no glycosylation site and resistance site mutations. However, H3N2 strains had mutations at receptor binding sites, antigenic sites, glycosylation sites, and resistance sites. The B/Victoria strains had antigenic site mutations, but no drug resistance site mutations. Moreover, only strains from 2021 to 2022 exhibit a glycosylation site mutation. CONCLUSION: Genetic characteristics analysis was conducted for the first time on H1N1, H3N2, and B/Victoria viruses prevalent in Qingyang, which enables us to understand the molecular evolution and amino acid mutations of HA and NA. CLINICAL TRIAL NUMBER: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-026-12853-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。